Co-Authors
This is a "connection" page, showing publications co-authored by Wendy Stock and Vishal Gupta.
Connection Strength
0.124
-
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL. J Clin Oncol. 2024 Oct 17; JCO2400321.
Score: 0.062
-
Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood Adv. 2024 Aug 02.
Score: 0.061